Lien MY, Wang TH, Hsieh CY, Tsai MH, et al. Both combined or sequential use with immune checkpoint inhibitors on cetuximab-treated patients with recurrent or metastatic head and neck squamous cell carcinoma improve the overall survival. Oral Oncol 2021;119:105380.
PMID: 34146822